BioSpace News Archive

Business

Sidero Bioscience Announces Agreement with SRS Life Sciences for Commercialization of BioFe for Iron Deficiency

Sidero Bioscience, LLC, a clinical stage biotechnology company targeting human digestive health, announces the execution of a term sheet agreement with SRS Life Sciences PTE. LTD, a leading life sciences company.

October 13, 2020
·
3 min read
Genetown

IONTAS Announces Mammalian Display Licensing Agreement With Bristol Myers Squibb

IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells

October 13, 2020
·
2 min read
Genetown

Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells

New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform

October 13, 2020
·
2 min read
AlzeCure gets abstract on the NeuroRestore platform against Alzheimer’s accepted for poster presentation at CTAD

AlzeCure Pharma AB announced that the company has received a second abstract approved for poster presentation at the annual Alzheimer’s conference CTAD, Clinical Trials in Alzheimer’s Disease, which this year will be held completely digitally on November 4-7.

October 13, 2020
·
5 min read
Business

Panaxia continues to grow: Panaxia Global Reports that Panaxia Israel ended the 3rd quarter of 2020 with record revenues of at least 16.3 million, growing by over three times YoY

The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd., the largest manufacturer of medical cannabis products in Israel, issued a preliminary revenue outlook for the 3rd quarter of 2020.

October 13, 2020
·
2 min read
Business

RadioMedix appointed Dr.Ferey Faridian as new member of the Board of Director

Radiomedix a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer, announced the appointment of Dr. Ferey Faridian as a member of its Board of Directors.

October 13, 2020
·
2 min read
Business

Iksuda Therapeutics Enters License Agreement With University of Goettingen to Develop a New Generation of Antibody Drug Conjugates

Iksuda licenses novel protein-alkylating, tumour-activated pro-drug payload series to develop ADCs with enhanced therapeutic index

October 13, 2020
·
3 min read
Bio NC

US researchers seeking 6,000+ participants for world’s largest eating disorders genetics study

University of North Carolina researchers are seeking more than 6,000 participants aged 18 years and over, with first-hand experience of eating disorders to enroll in the world’s largest ever genetic research study into three complex, devastating mental illnesses.

October 13, 2020
·
8 min read
Business

Inozyme Pharma Appoints Yves Sabbagh, Ph.D., as Senior Vice President and Chief Scientific Officer

Dr. Sabbagh Brings More Than 20 Years of Experience in Rare Genetic Disorders and Mineral Metabolism Research Development Programs

October 13, 2020
·
6 min read
Drug Development

Randomized Controlled Phase 3 Trial of Remestemcel-L for Reduced Mortality in COVID-19 Acute Respiratory Distress Syndrome Surpasses 50% Enrollment

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that the randomized controlled Phase 3 trial of remestemcel-L on top of maximal care in ventilator-dependent patients with acute respiratory distress syndrome due to COVID-19 infection has surpassed 50% enrollment.

October 13, 2020
·
6 min read